ABT logo

Abbott Laboratories (ABT) Cash from financing

annual CFF:

-$5.40B+$1.69B(+23.79%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ABT annual cash flow from financing activities is -$5.40 billion, with the most recent change of +$1.69 billion (+23.79%) on December 31, 2024.
  • During the last 3 years, ABT annual CFF has risen by +$90.00 million (+1.64%).
  • ABT annual CFF is now -148.48% below its all-time high of $11.15 billion, reached on December 31, 2016.

Performance

ABT Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

quarterly CFF:

-$2.06B-$194.00M(-10.42%)
March 1, 2025

Summary

  • As of today (May 29, 2025), ABT quarterly cash flow from financing activities is -$2.06 billion, with the most recent change of -$194.00 million (-10.42%) on March 1, 2025.
  • Over the past year, ABT quarterly CFF has dropped by -$879.00 million (-74.74%).
  • ABT quarterly CFF is now -115.22% below its all-time high of $13.50 billion, reached on December 31, 2016.

Performance

ABT quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

TTM CFF:

-$6.28B-$879.00M(-16.27%)
March 1, 2025

Summary

  • As of today (May 29, 2025), ABT TTM cash flow from financing activities is -$6.28 billion, with the most recent change of -$879.00 million (-16.27%) on March 1, 2025.
  • Over the past year, ABT TTM CFF has increased by +$574.00 million (+8.37%).
  • ABT TTM CFF is now -156.36% below its all-time high of $11.15 billion, reached on December 31, 2016.

Performance

ABT TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ABT Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+23.8%-74.7%+8.4%
3 y3 years+1.6%+46.3%+24.8%
5 y5 years-26.0%-179.6%-61.9%

ABT Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+29.2%-159.8%+46.3%-20.3%+24.8%
5 y5-year-94.5%+29.2%-412.3%+46.3%-126.4%+24.8%
alltimeall time-148.5%+48.0%-115.2%+68.2%-156.4%+39.5%

ABT Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$2.06B(+10.4%)
-$6.28B(+16.3%)
Dec 2024
-$5.40B(-23.8%)
-$1.86B(+18.1%)
-$5.40B(-3.4%)
Sep 2024
-
-$1.58B(+99.2%)
-$5.59B(-12.0%)
Jun 2024
-
-$791.00M(-32.7%)
-$6.36B(-7.3%)
Mar 2024
-
-$1.18B(-42.7%)
-$6.86B(-3.3%)
Dec 2023
-$7.09B(-7.1%)
-$2.05B(-12.3%)
-$7.09B(+9.2%)
Sep 2023
-
-$2.34B(+81.5%)
-$6.50B(+14.0%)
Jun 2023
-
-$1.29B(-8.6%)
-$5.70B(+9.1%)
Mar 2023
-
-$1.41B(-3.2%)
-$5.22B(-31.6%)
Dec 2022
-$7.64B(+39.0%)
-$1.46B(-5.6%)
-$7.64B(-5.3%)
Sep 2022
-
-$1.54B(+89.8%)
-$8.06B(+2.1%)
Jun 2022
-
-$813.00M(-78.7%)
-$7.90B(-5.4%)
Mar 2022
-
-$3.82B(+102.7%)
-$8.35B(+52.0%)
Dec 2021
-$5.49B(+97.7%)
-$1.89B(+37.0%)
-$5.49B(+25.0%)
Sep 2021
-
-$1.38B(+8.9%)
-$4.39B(-10.9%)
Jun 2021
-
-$1.26B(+30.7%)
-$4.93B(+63.8%)
Mar 2021
-
-$967.00M(+22.9%)
-$3.01B(+8.3%)
Dec 2020
-$2.78B(-35.2%)
-$787.00M(-58.9%)
-$2.78B(-33.5%)
Sep 2020
-
-$1.92B(-391.0%)
-$4.18B(+50.5%)
Jun 2020
-
$658.00M(-189.5%)
-$2.77B(-28.5%)
Mar 2020
-
-$735.00M(-66.4%)
-$3.88B(-9.5%)
Dec 2019
-$4.29B(-58.7%)
-$2.19B(+325.9%)
-$4.29B(-37.7%)
Sep 2019
-
-$513.00M(+14.3%)
-$6.88B(+76.6%)
Jun 2019
-
-$449.00M(-60.7%)
-$3.90B(-23.3%)
Mar 2019
-
-$1.14B(-76.1%)
-$5.08B(-51.1%)
Dec 2018
-$10.39B(+96.8%)
-$4.78B(-293.3%)
-$10.39B(+81.4%)
Sep 2018
-
$2.47B(-251.5%)
-$5.73B(-33.3%)
Jun 2018
-
-$1.63B(-74.7%)
-$8.58B(+17.0%)
Mar 2018
-
-$6.46B(+5663.4%)
-$7.34B(+38.9%)
Dec 2017
-$5.28B(-147.4%)
-$112.00M(-71.0%)
-$5.28B(-163.4%)
Sep 2017
-
-$386.00M(+0.5%)
$8.34B(+4.5%)
Jun 2017
-
-$384.00M(-91.3%)
$7.97B(-2.5%)
Mar 2017
-
-$4.40B(-132.6%)
$8.18B(-26.6%)
Dec 2016
$11.15B(-598.5%)
$13.50B(-1910.2%)
$11.15B(-490.6%)
Sep 2016
-
-$746.00M(+316.8%)
-$2.85B(-2.4%)
Jun 2016
-
-$179.00M(-87.5%)
-$2.92B(-6.3%)
Mar 2016
-
-$1.43B(+188.1%)
-$3.12B(+39.4%)
Dec 2015
-$2.24B(-18.5%)
-$497.00M(-39.0%)
-$2.24B(-8.3%)
Sep 2015
-
-$815.00M(+117.9%)
-$2.44B(+28.7%)
Jun 2015
-
-$374.00M(-32.0%)
-$1.90B(-11.4%)
Mar 2015
-
-$550.00M(-21.4%)
-$2.14B(-22.0%)
Dec 2014
-$2.74B(-59.1%)
-$700.00M(+158.3%)
-$2.74B(-29.9%)
Sep 2014
-
-$271.00M(-56.2%)
-$3.91B(-6.9%)
Jun 2014
-
-$619.00M(-46.3%)
-$4.20B(+34.8%)
Mar 2014
-
-$1.15B(-38.4%)
-$3.12B(-53.5%)
Dec 2013
-$6.70B(-3533.8%)
-$1.87B(+234.3%)
-$6.70B(+188.4%)
Sep 2013
-
-$559.00M(-220.2%)
-$2.32B(-46.7%)
Jun 2013
-
$465.00M(-109.8%)
-$4.35B(-7.4%)
Mar 2013
-
-$4.73B(-288.9%)
-$4.70B(-2511.9%)
Dec 2012
$195.00M(-103.0%)
$2.51B(-196.7%)
$195.00M(-104.9%)
Sep 2012
-
-$2.59B(-2345.8%)
-$3.99B(-1.9%)
Jun 2012
-
$115.37M(-30.2%)
-$4.07B(-26.9%)
Mar 2012
-
$165.22M(-109.8%)
-$5.57B(-13.2%)
Dec 2011
-$6.42B(+490.5%)
-$1.68B(-36.9%)
-$6.42B(+32.9%)
Sep 2011
-
-$2.67B(+92.5%)
-$4.83B(+69.5%)
Jun 2011
-
-$1.39B(+102.6%)
-$2.85B(+127.7%)
Mar 2011
-
-$684.33M(+633.4%)
-$1.25B(+15.1%)
Dec 2010
-$1.09B(-208.6%)
-$93.31M(-86.4%)
-$1.09B(+121.5%)
Sep 2010
-
-$687.11M(-422.8%)
-$491.05M(-25.6%)
Jun 2010
-
$212.88M(-140.9%)
-$660.28M(-45.1%)
Mar 2010
-
-$520.20M(-203.3%)
-$1.20B(-220.0%)
Dec 2009
$1.00B(-128.7%)
$503.37M(-158.8%)
$1.00B(+83.3%)
Sep 2009
-
-$856.33M(+159.8%)
$546.52M(-127.9%)
Jun 2009
-
-$329.62M(-119.6%)
-$1.96B(+24.6%)
Mar 2009
-
$1.68B(+3418.8%)
-$1.58B(-54.8%)
Dec 2008
-$3.49B(+50.7%)
$47.88M(-101.4%)
-$3.49B(-12.6%)
Sep 2008
-
-$3.37B(-5933.9%)
-$3.99B(+176.6%)
Jun 2008
-
$57.68M(-125.5%)
-$1.44B(-29.0%)
Mar 2008
-
-$226.27M(-50.4%)
-$2.03B(-12.1%)
Dec 2007
-$2.31B
-$455.78M(-44.3%)
-$2.31B(-405.8%)
Sep 2007
-
-$817.97M(+53.7%)
$756.24M(+94.4%)
DateAnnualQuarterlyTTM
Jun 2007
-
-$532.22M(+5.0%)
$389.04M(-91.5%)
Mar 2007
-
-$506.66M(-119.4%)
$4.57B(+26.1%)
Dec 2006
$3.62B(-239.7%)
$2.61B(-320.5%)
$3.62B(+1036.9%)
Sep 2006
-
-$1.19B(-132.5%)
$318.58M(-82.3%)
Jun 2006
-
$3.64B(-351.3%)
$1.80B(-149.9%)
Mar 2006
-
-$1.45B(+110.1%)
-$3.61B(+39.3%)
Dec 2005
-$2.59B(+491.4%)
-$690.26M(-330.2%)
-$2.59B(+22.6%)
Sep 2005
-
$299.79M(-116.9%)
-$2.11B(-38.0%)
Jun 2005
-
-$1.77B(+311.2%)
-$3.41B(+272.9%)
Mar 2005
-
-$430.72M(+102.4%)
-$914.38M(+108.6%)
Dec 2004
-$438.32M(-78.2%)
-$212.83M(-78.6%)
-$438.32M(-61.0%)
Sep 2004
-
-$995.05M(-237.4%)
-$1.12B(+1529.2%)
Jun 2004
-
$724.22M(+1497.3%)
-$68.95M(-95.6%)
Mar 2004
-
$45.34M(-105.0%)
-$1.55B(-22.7%)
Dec 2003
-$2.01B(-13.2%)
-$897.95M(-1610.9%)
-$2.01B(+0.8%)
Sep 2003
-
$59.43M(-107.8%)
-$1.99B(-14.2%)
Jun 2003
-
-$758.52M(+85.4%)
-$2.32B(+9.7%)
Mar 2003
-
-$409.18M(-53.6%)
-$2.11B(-8.5%)
Dec 2002
-$2.31B(-150.0%)
-$881.67M(+225.9%)
-$2.31B(+40.3%)
Sep 2002
-
-$270.51M(-51.0%)
-$1.65B(-20.0%)
Jun 2002
-
-$552.56M(-8.7%)
-$2.06B(+68.6%)
Mar 2002
-
-$605.24M(+177.3%)
-$1.22B(-126.4%)
Dec 2001
$4.62B(-315.3%)
-$218.22M(-68.0%)
$4.62B(+6.2%)
Sep 2001
-
-$682.60M(-339.8%)
$4.36B(-1.7%)
Jun 2001
-
$284.69M(-94.6%)
$4.43B(+34.6%)
Mar 2001
-
$5.24B(-1177.4%)
$3.29B(-253.4%)
Dec 2000
-$2.15B(+50.5%)
-$486.35M(-19.7%)
-$2.15B(+44.1%)
Sep 2000
-
-$605.54M(-29.1%)
-$1.49B(+15.1%)
Jun 2000
-
-$854.04M(+322.7%)
-$1.29B(+33.5%)
Mar 2000
-
-$202.03M(-217.8%)
-$969.23M(-32.1%)
Dec 1999
-$1.43B(+15.7%)
$171.46M(-141.8%)
-$1.43B(-12.7%)
Sep 1999
-
-$409.76M(-22.5%)
-$1.63B(+0.7%)
Jun 1999
-
-$528.91M(-19.8%)
-$1.62B(+32.1%)
Mar 1999
-
-$659.59M(+1773.8%)
-$1.23B(-0.4%)
Dec 1998
-$1.23B(-4.3%)
-$35.20M(-91.2%)
-$1.23B(-13.5%)
Sep 1998
-
-$397.98M(+194.3%)
-$1.43B(+5.0%)
Jun 1998
-
-$135.22M(-79.7%)
-$1.36B(-3.2%)
Mar 1998
-
-$664.80M(+192.0%)
-$1.40B(+8.8%)
Dec 1997
-$1.29B(+117.6%)
-$227.70M(-31.0%)
-$1.29B(+1.6%)
Sep 1997
-
-$330.11M(+83.6%)
-$1.27B(-1.2%)
Jun 1997
-
-$179.84M(-67.4%)
-$1.28B(+169.1%)
Mar 1997
-
-$551.36M(+166.5%)
-$477.15M(-19.4%)
Dec 1996
-$592.30M(-36.6%)
-$206.85M(-40.2%)
-$592.30M(-7.6%)
Sep 1996
-
-$346.14M(-155.2%)
-$640.97M(+33.2%)
Jun 1996
-
$627.20M(-194.1%)
-$481.04M(-65.3%)
Mar 1996
-
-$666.50M(+160.8%)
-$1.38B(+48.3%)
Dec 1995
-$933.87M(-27.0%)
-$255.53M(+37.2%)
-$933.87M(-7.5%)
Sep 1995
-
-$186.21M(-32.7%)
-$1.01B(-7.6%)
Jun 1995
-
-$276.61M(+28.3%)
-$1.09B(+4.7%)
Mar 1995
-
-$215.53M(-35.0%)
-$1.04B(-18.4%)
Dec 1994
-$1.28B(+48.2%)
-$331.37M(+23.0%)
-$1.28B(+10.8%)
Sep 1994
-
-$269.51M(+18.4%)
-$1.15B(+0.6%)
Jun 1994
-
-$227.64M(-49.6%)
-$1.15B(+8.9%)
Mar 1994
-
-$451.41M(+118.7%)
-$1.05B(+22.1%)
Dec 1993
-$863.87M(+31.4%)
-$206.37M(-21.6%)
-$863.87M(+7.1%)
Sep 1993
-
-$263.10M(+96.2%)
-$806.60M(+39.2%)
Jun 1993
-
-$134.10M(-48.5%)
-$579.40M(-32.2%)
Mar 1993
-
-$260.30M(+74.6%)
-$854.80M(+30.0%)
Dec 1992
-$657.50M(-15.7%)
-$149.10M(+315.3%)
-$657.50M(-0.7%)
Sep 1992
-
-$35.90M(-91.2%)
-$661.90M(-23.5%)
Jun 1992
-
-$409.50M(+550.0%)
-$865.70M(+40.2%)
Mar 1992
-
-$63.00M(-59.0%)
-$617.40M(-20.8%)
Dec 1991
-$779.80M(+39.7%)
-$153.50M(-36.0%)
-$779.80M(-26.9%)
Sep 1991
-
-$239.70M(+48.7%)
-$1.07B(+13.5%)
Jun 1991
-
-$161.20M(-28.5%)
-$939.80M(+15.4%)
Mar 1991
-
-$225.40M(-48.8%)
-$814.50M(+45.9%)
Dec 1990
-$558.20M(-40.4%)
-$440.10M(+289.1%)
-$558.20M(+372.7%)
Sep 1990
-
-$113.10M(+215.0%)
-$118.10M(+2262.0%)
Jun 1990
-
-$35.90M(-216.2%)
-$5.00M(-116.2%)
Mar 1990
-
$30.90M
$30.90M
Dec 1989
-$935.90M
-
-

FAQ

  • What is Abbott Laboratories annual cash flow from financing activities?
  • What is the all time high annual CFF for Abbott Laboratories?
  • What is Abbott Laboratories annual CFF year-on-year change?
  • What is Abbott Laboratories quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Abbott Laboratories?
  • What is Abbott Laboratories quarterly CFF year-on-year change?
  • What is Abbott Laboratories TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Abbott Laboratories?
  • What is Abbott Laboratories TTM CFF year-on-year change?

What is Abbott Laboratories annual cash flow from financing activities?

The current annual CFF of ABT is -$5.40B

What is the all time high annual CFF for Abbott Laboratories?

Abbott Laboratories all-time high annual cash flow from financing activities is $11.15B

What is Abbott Laboratories annual CFF year-on-year change?

Over the past year, ABT annual cash flow from financing activities has changed by +$1.69B (+23.79%)

What is Abbott Laboratories quarterly cash flow from financing activities?

The current quarterly CFF of ABT is -$2.06B

What is the all time high quarterly CFF for Abbott Laboratories?

Abbott Laboratories all-time high quarterly cash flow from financing activities is $13.50B

What is Abbott Laboratories quarterly CFF year-on-year change?

Over the past year, ABT quarterly cash flow from financing activities has changed by -$879.00M (-74.74%)

What is Abbott Laboratories TTM cash flow from financing activities?

The current TTM CFF of ABT is -$6.28B

What is the all time high TTM CFF for Abbott Laboratories?

Abbott Laboratories all-time high TTM cash flow from financing activities is $11.15B

What is Abbott Laboratories TTM CFF year-on-year change?

Over the past year, ABT TTM cash flow from financing activities has changed by +$574.00M (+8.37%)
On this page